China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study of ex vivo organ perfusion preservation to improve post-transplant telo... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ivosiditumab Combined with Chemotherapy as Neoadjuvant Therapy ... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of Efficacy and Safety between Magnetic Seizure Therapy and Modified Electr... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Intervention Study on Improving Urinary Incontinence through Pelvic Floor Muscle Train... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Oxycodone/Naloxone Sustained-Release Tablets on Progression-Free Survival i... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effect and Mechanism of Correcting Vitamin D Deficiency on Chronic Atroph... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic value of Trop2-targeted immuno-PET/CT in disease postoperative assessment o... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Impact and Mechanism of Gastric Acid on the Efficacy of Endoscopic Ultrasound-Guided T... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Cerebrovascular disease：Medical and nursing collaboration appointment outpatient re-co... Read More
China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Ipilimumab/Tuvonralimab Combined with FOLFOXIRI and Targeted Therapy for the Treatment... Read More